SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-055651
Filing Date
2024-05-08
Accepted
2024-05-08 16:10:52
Documents
73
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bdsx-20240331.htm   iXBRL 10-Q 1637819
2 EX-31.1 bdsx-ex31_1.htm EX-31.1 14123
3 EX-31.2 bdsx-ex31_2.htm EX-31.2 14141
4 EX-32.1 bdsx-ex32_1.htm EX-32.1 7378
5 EX-32.2 bdsx-ex32_2.htm EX-32.2 7603
  Complete submission text file 0000950170-24-055651.txt   8915079

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bdsx-20240331.xsd EX-101.SCH 1821097
77 EXTRACTED XBRL INSTANCE DOCUMENT bdsx-20240331_htm.xml XML 1319086
Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

IRS No.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39659 | Film No.: 24926123
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)